0001193125-24-218131 Sample Contracts

10,666,600 Shares of Common Stock 20,000 Shares of Series B Preferred Stock Viridian Therapeutics, Inc. UNDERWRITING AGREEMENT

Underwriting Agreement • September 12th, 2024 • Viridian Therapeutics, Inc.\DE • Services-medical laboratories • New York

• Contract Type
  Underwriting Agreement
• Filed
  September 12th, 2024
• Company
  Viridian Therapeutics, Inc.\DE
• Industry
  Services-medical laboratories
• Jurisdiction
  New York